Vivienne Michael, Chief Executive of
Deafness Research UK
Chaired by Professor David Moore, Director of the MRC Institute for Hearing Research, the seminar on Monday 21 March at the CBI Conference Suite in London aims to bring together both researchers and clinicians to discuss the latest advances in the field, from both investigative and medical perspectives.
A branch of biomedicine, otology studies the normal and pathological anatomy and physiology of the ear, together with its diseases, diagnosis and treatment. Its key areas of concern consist of identifying the underlying mechanisms of Meniere’s disease, tinnitus, otitis media (glue ear) the use of cochlear implants and age-related hearing loss (presbycusis) – all of which are priority targets for Deafness Research UK.
Commenting on the seminar, Professor Dave Moore said: “In bringing together eminent professionals from the worlds of hearing and molecular biology, we are providing a regular forum for the advancement of scientific understanding and clinical development in biomedical approaches to ear diseases. We expect the seminar to deliver tangible conclusions that will help steer medical research in otology at the molecular level in the future.”
"We are delighted to be hosting this Recent Advances in Molecular Biology of Otology meeting,” said Vivienne Michael, Chief Executive of Deafness Research UK. “Bringing researchers and clinicians together to discuss their findings is essential in seeing developments in this vital field continue to bear fruit, offering hope for all those people who are waiting for new treatments and cures.”
This Recent Advances in Molecular Biology of Otology will be a groundbreaking forum where leaders in the field can showcase their advances in these key areas and the development of clinical treatments. The event is a must-attend for researchers, clinicians and audiologists together with genetic councillors in hearing disorders and all medical professionals with an interest in the latest research in genetics.
The programme will focus on three key topics: understanding the genetics of presbycusis, recent advances in stem cell treatments and applying the genetics of otitis media to the clinic. Key speakers include: Dr Sally Dawson, UCL Ear Institute, Dr Louisa Murdin, National Hospital for Neurology and Neurosurgery, Dr Marcelo Rivolta, University of Sheffield, Professor Gerard O'Donoghue, Queens Medical Centre, Nottingham, Dr Michael Cheeseman, MRC Harwell and Dr Mahmood Bhutta, University of Oxford.
For full details of the seminar programme and to book your place, visit http://www.deafnessresearch.org.uk/6161/news/recent-advances-in-molecular-biology-of-otology-meeting-2011.html